VYNE CIK: 1566044

Yarrow Bioscience, Inc. (VYNE)

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
63.2
FY22:
38.3
FY23:
96.0
FY24:
64.4
FY25:
30.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.86
FY22:
2.48
FY23:
1.72
FY24:
2.47
FY25:
0.15
Total assets
Change from FY21 to FY25
millions USD
FY21:
67.0
FY22:
40.8
FY23:
97.7
FY24:
66.9
FY25:
30.2

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
18.4
FY22:
9.35
FY23:
7.54
FY24:
14.8
FY25:
2.40
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
1.41
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
48.6
FY22:
31.2
FY23:
88.7
FY24:
52.1
FY25:
27.8
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
67.0
FY22:
40.5
FY23:
97.7
FY24:
66.9
FY25:
30.2

All amounts in millions USD Data source:SEC EDGAR